Abstract

Objective: Traumatic brain injury (TBI) is a leading cause of death and disability in the pediatric age group. This study aimed to investigate the effectiveness of serum S100 calcium-binding protein B (S100b), ubiquitin carboxyterminal hydrolase-like1 (UCH-L1), glial fibrillary acidic protein (GFAP), and neurofilament (NF) protein levels in predicting the diagnosis and prognosis of traumatic brain injury.

Methods: The research comprised head trauma patients aged 1 month to 18 years hospitalized at Mersin University Faculty of Medicine between October 2018 and November 2019. We recorded the demographic data of the patients, the type of trauma, the treatments administered in the pediatric intensive care unit (PICU), the Glasgow Coma Scale (GCS), the Pediatric Trauma Score (PTS), and the computed cerebral tomography (CT) reports. S-100b protein, UCHL-1, GFAP, and NF levels of the patients and control group were checked. The correlation between serum levels of biomarkers and GCS, CT findings, Rotterdam score, and Glasgow Outcome Scale-Extended (GOS-E) score of the patients was analyzed statistically.

Results: The study included 73 patients, 49 males and 24 females. Comparing the groups revealed no statistically significant correlation between GFAP and TBI (p>0.05). However, the correlation between S-100b, UCHL-1, and NF and patient groups was statistically significant (p<0.05). The NF level was statistically higher in the PICU 24-hour group than in the control and pediatric emergency groups but statistically lower compared to the PICU 48-hour group (p<0.05). UCHL-1 levels in the PICU 24-hour group were statistically higher than those in the control group (p<0.05). The inverse correlation between GOS-E and UCHL-1 in the PICU 24-hour group was statistically significant (p<0.05). Patients with CT findings had a higher UCHL-1 level than those without (p<0.05).

Conclusion: S-100b, UCHL-1, and NF may be used for the diagnosis of TBI and evaluation of its severity. Furthermore, UCHL-1 has the potential to be useful in forecasting patients’ prognoses.

Keywords: traumatic brain injury, biomarkers, glial fibrillary acidic protein, ubiquitin carboxyterminal hydrolase-like1

Copyright and license

Copyright © 2024 The author(s). This is an open-access article published by Aydın Pediatric Society under the terms of the Creative Commons Attribution License (CC BY) which permits unrestricted use, distribution, and reproduction in any medium or format, provided the original work is properly cited.

How to cite

1.
Nabiyeva Çevik N, Korulmaz A, Alakaya M, Ten B, Eroğlan Ç, Çimen MBY, et al. Use of serum biomarkers in the diagnosis of traumatic brain injury. Trends in Pediatrics. 2024;5(4):130-138. https://doi.org/10.59213/TP.2024.172

References

  1. Smits M, Dippel DWJ, de Haan GG, et al. External validation of the Canadian CT Head Rule and the New Orleans Criteria for CT scanning in patients with minor head injury. JAMA. 2005;294:1519-25. [Crossref]
  2. Gennarelli TA. Mechanisms of brain injury. J Emerg Med. 1993;11(Suppl 1):5-11.
  3. Blyth BJ, Farhavar A, Gee C, et al. Validation of serum markers for blood-brain barrier disruption in traumatic brain injury. J Neurotrauma. 2009;26:1497-507. [Crossref]
  4. Brophy GM, Mondello S, Papa L, et al. Biokinetic analysis of ubiquitin C-terminal hydrolase-L1 (UCH-L1) in severe traumatic brain injury patient biofluids. J Neurotrauma. 2011;28:861-70. [Crossref]
  5. Siman R, Toraskar N, Dang A, et al. A panel of neuron-enriched proteins as markers for traumatic brain injury in humans. J Neurotrauma. 2009;26:1867-77. [Crossref]
  6. Summers CR, Ivins B, Schwab KA. Traumatic brain injury in the United States: an epidemiologic overview. Mt Sinai J Med. 2009;76:105-10. [Crossref]
  7. Wang KK, Yang Z, Zhu T, et al. An update on diagnostic and prognostic biomarkers for traumatic brain injury. Expert Rev Mol Diagn. 2018;18:165-80. [Crossref]
  8. Tintinalli JE, Stapczynski JS, Cline DM, Ma OJ, Cydulka RK, Meckler GD. Emergency medicine: a comprehensive study guide. 7th ed. New York: McGraw-Hill, Medical Pub; 2013: 1692-1709.
  9. Zurek J, Fedora M. Dynamics of glial fibrillary acidic protein during traumatic brain injury in children. J Trauma. 2011;71:854-9. [Crossref]
  10. Yousefzadeh-Chabok S, Kazemnejad-Leili E, Kouchakinejad-Eramsadati L, et al. Comparing Pediatric Trauma, Glasgow Coma Scale and Injury Severity scores for mortality prediction in traumatic children. Ulus Travma Acil Cerrahi Derg. 2016;22:328-32. [Crossref]
  11. Faul M, Coronado V. Epidemiology of traumatic brain injury. Handb Clin Neurol. 2015;127:3-13. [Crossref]
  12. Işık HS, Gökyar A, Yıldız O, Bostancı U, Ozdemir C. Pediatric head injuries, retrospective analysis of 851 patients: an epidemiological study. Ulus Travma Acil Cerrahi Derg. 2011;17:166-72. [Crossref]
  13. Şimşek O, Hiçdönmez T, Hamamcıoğlu MK, et al. Pediatric head injuries: a retrospective analysis of 280 patients. Ulus Travma Acil Cerrahi Derg. 2005;11(4):310-7.
  14. Adegoke SA, Oginni LM. Predictors of paediatric injury mortality. South African Journal of Child Health. 2011;5(1):15-8.
  15. Lazar L, Erez I, Gutermacher M, Katz S. Brain concussion produces transient hypokalemia in children. J Pediatr Surg. 1997;32:88-90. [Crossref]
  16. Grinkeviciūte DE, Kevalas R, Saferis V, Matukevicius A, Ragaisis V, Tamasauskas A. Predictive value of scoring system in severe pediatric head injury. Medicina (Kaunas). 2007;43:861-9.
  17. Ghaffarpasand F, Razmkon A, Dehghankhalili M. Glasgow Coma Scale score in pediatric patients with traumatic brain injury; Limitations and reliability. Bull Emerg Trauma. 2013;1(4):135-6.
  18. Papa L, Lewis LM, Silvestri S, et al. Serum levels of ubiquitin C-terminal hydrolase distinguish mild traumatic brain injury from trauma controls and are elevated in mild and moderate traumatic brain injury patients with intracranial lesions and neurosurgical intervention. J Trauma Acute Care Surg. 2012;72:1335-44. [Crossref]
  19. Eng LF, Vanderhaeghen JJ, Bignami A, Gerstl B. An acidic protein isolated from fibrous astrocytes. Brain Res. 1971;28:351-4. [Crossref]
  20. Honda M, Tsuruta R, Kaneko T, et al. Serum glial fibrillary acidic protein is a highly specific biomarker for traumatic brain injury in humans compared with S-100B and neuron-specific enolase. J Trauma. 2010;69:104-9. [Crossref]
  21. Lei J, Gao G, Feng J, et al. Glial fibrillary acidic protein as a biomarker in severe traumatic brain injury patients: a prospective cohort study. Crit Care. 2015;19:362. [Crossref]
  22. Papa L, Brophy GM, Welch RD, et al. Time course and diagnostic accuracy of glial and neuronal blood biomarkers GFAP and UCH-L1 in a large cohort of trauma patients with and without mild traumatic brain injury. JAMA Neurol. 2016;73:551-60. [Crossref]
  23. Babcock L, Byczkowski T, Mookerjee S, Bazarian JJ. Ability of S100B to predict severity and cranial CT results in children with TBI. Brain Inj. 2012;26:1372-80. [Crossref]
  24. Abbasi M, Sajjadi M, Fathi M, Maghsoudi M. Serum S100B Protein as an Outcome Prediction Tool in Emergency Department Patients with Traumatic Brain Injury. Turk J Emerg Med. 2016;14:147-52. [Crossref]
  25. Gatson JW, Barillas J, Hynan LS, Diaz-Arrastia R, Wolf SE, Minei JP. Detection of neurofilament-H in serum as a diagnostic tool to predict injury severity in patients who have suffered mild traumatic brain injury. J Neurosurg. 2014;121:1232-8. [Crossref]